Myoderm Joins SCRS as Global Impact Partner

May 11, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization.

The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization. Myoderm will participate as a Global Impact Partner (GIP) and align with sponsors, CROs and other industry solution providers who share an ongoing commitment to promoting site sustainability across the clinical trials landscape.

 

Read the full release here.

Related Content:

News